Hosted on MSN
EU launches antitrust probe into Sanofi over allegedly misleading flu vaccine claims (updated)
Editor’s Note: Updated with Sanofi’s comments after the company responded to Benzinga’s request for comment. The European Commission has launched a formal antitrust investigation into Sanofi SNY to ...
Sanofi Canada has inaugurated its new $925M facility to produce flu vaccines in Toronto, the Charles Best Building. Named ...
Sanofi announced the inauguration of the Charles Best Building, a new influenza vaccine manufacturing facility in Toronto, Canada, following a C$925 million investment to expand t ...
The European Commission on Wednesday announced that Sanofi (SNY) has agreed to stop disparaging a rival flu vaccine developed by CSL Limited (CSLLY) after the French drugmaker faced an EU antitrust ...
Sanofi today inaugurated the Charles Best Building, a flu vaccine manufacturing facility that will manufacture Sanofi's Fluzone® High-Dose influenza vaccine. This new manufacturing facility also ...
Flu vaccines are a major business for French pharmaceutical group Sanofi – Copyright AFP GUILLAUME SOUVANT The European Commission announced Friday that it was ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sanofi says the facility also adds industrial‑scale, end‑to‑end vaccine manufacturing capacity on Canadian soil.
According to the Financial Times, in an article by Patricia Nilsson, EU competition authorities are examining whether Sanofi disseminated misleading information that unfairly discredited a rival ...
Project started during height of COVID-19 pandemic and is now opening during another surge in interest in domestic drug ...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...
The European Commission announced Friday that it was opening an antitrust probe into French pharmaceutical group Sanofi on suspicion it breached the bloc's competition rules in promoting a flu vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results